Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer

NCT02358473

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Horizon Oncology Lafayette, Indiana, United States
  • John Hopkins University School of Medicine Baltimore, Maryland, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • MD Anderson Houston, Texas, United States
View Trial Details
Completed

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

NCT03473925

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Honor Health ( Site 0005) Scottsdale, Arizona, United States
  • Florida Cancer Specialists ( Site 0003) Sarasota, Florida, United States
  • University of Maryland ( Site 0008) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0006) Detroit, Michigan, United States
View all 14 locations
View Trial Details
Completed

Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)

NCT03664024

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +13 more
Locations
  • University Of Colorado ( Site 0908) Aurora, Colorado, United States
  • Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0903) Detroit, Michigan, United States
  • Kingston General Hospital ( Site 0800) Kingston, Ontario, Canada
View all 15 locations
View Trial Details
Completed

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

NCT02679170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Clínico Univ. de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Complejo Hospitalario de Jerez Jerez de la Frontera, Cadiz, Spain
  • Hospital Marqués de Valdecilla Santander, Cantabria, Spain
View all 32 locations
View Trial Details
Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details

Related conditions